Objective: To evaluate the implementation of telecytology in an academic cytology service for immediate assessment of endoscopic ultrasound (EUS) and endobronchoscopic ultrasound (EBUS) fine-needle aspiration (FNA). Study Design: Telecytology was evaluated over a 10-month period. Using an Olympus BX41® microscope and an Olympus DP72® camera with Olympus cellSens® software, real-time dynamic images of air-dried Diff-Quik®-stained smears were transmitted by a cytopathology fellow or cytotechnologist using a secure internet connection. The cytopathologists remotely accessed the real-time images on a computer in their office and rendered immediate assessments. Mean procedure times, and preliminary and final diagnoses were compared between telecytology and conventional on-site evaluation. Results: Two hundred and forty consecutive EUS-FNA and EBUS-FNA procedures with immediate assessments were performed during the evaluation period, of which 158 (66%) utilized telecytology and 82 (34%) did not utilize telecytology. The mean procedure time required for cytotechnologists and cytology fellows was 1.1 h for both conventional on-site and telecytology evaluations. The mean procedure time for cytopathologists was 0.74 h for conventional on-site evaluations and 0.2 h for telecytology. Conclusions: Incorporation of telecytology for immediate assessment of EUS-FNA increased cytopathologist efficiency.

O’Brien MJ, Takahashi M, Brugal G, Christen H, Gahm T, Goodell RM, et al: Digital imagery/telecytology: International Academy of Cytology Task Force Summary – diagnostic cytology towards the 21st century: an international expert conference and tutorial. Acta Cytol 1998;42:148–164.
Pantanowitz L, Hornish M, Goulart RA: The impact of digital imaging in the field of cytopathology. Cytojournal 2009;6:6.
Khalbuss WE, Pantanowitz L, Parwani AV: Digital imaging in cytopathology. Patholog Res Int 2011;2011:264683.
Thrall M, Pantanowitz, Khalbuss W: Telecytology: clinical implications, current challenges, and future benefits. J Pathol Inform 2011;2:51.
Kern I, Gabric S, Triller N, Pozek I: Telecytology for rapid assessment of cytological specimens. J Telemed Telecare 2012;18:86–89.
Alsharif M, Carlo-Demovich J, Massey C, Madory JE, Lewin D, Medina A, Recavarren R, Houser PM, Yang J: Telecytopathology for immediate evaluation of fine-needle aspiration specimens. Cancer Cytopathol 2010;118:119–126.
Kim B, Chhieng DC, Crowe DR, Jhala D, Jhala N, Winokur T, Eloubeidi MA, Eltoum IE: Dynamic telecytopathology of on site rapid cytology diagnoses for pancreatic carcinoma. Cytojournal 2006;3:27.
Heimann A, Maini G, Hwang S, Shroyer KR, Singh M: Use of telecytology for the immediate assessment of CT guided and endoscopic FNA cytology: diagnostic accuracy, advantages, and pitfalls. Diagn Cytopathol 2012;40:575–581.
Strawbridge H: Dropping downtime for immediate FNA evaluations. CAP Today 2011;25:5–6.
Nasuti JF, Gupta PK, Balock ZW: Diagnostic value and cost-effectiveness of on-site evaluation of fine-needle aspiration specimens: review of 5,688 cases. Diagn Cytopathol 2002;27:1–4.
Layfield LJ, Bentz JS, Gopez EV: Immediate on-site interpretation of fine-needle aspiration smears: a cost and compensation analysis. Cancer 2001;95:319–322.
Centers for Medicare & Medicaid Services: National Correct Coding Initiative Policy Manual for Medicare Services. http://www.cms.gov/NationalCorrectCodInitEd/ (accessed February 2, 2012).
Kerr SE, Bellizzi AM, Stelow EB, Frierson HF, Policarpio-Nicolas ML: Initial assessment of fine-needle aspiration specimens by telepathology: validation for use in pathology resident-faculty consultations. Am J Clin Pathol 2008;130:409–413.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.